课题基金 / 基金详情

SEX DIFFERENCES IN PHARMACOKINETICS OF LOPINAVIR/RITONAVIR AMONG HIV-1 INFECT

SEX DIFFERENCES IN PHARMACOKINETICS OF LOPINAVIR/RITONAVIR AMONG HIV-1 INFECT
HIV-1 感染者中洛匹那韦/利托那韦药代动力学的性别差异
批准号:
7717997
负责人:
Judith S. Currier
金额:
$1.23万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-12-01 至 2008-11-30

项目摘要

项目成果

Judith S. Currier的其他基金

相关文献

中文摘要
翻译
这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者(PI)可能从另一个NIH来源获得了主要资金, 因此可以在其他CRISP条目中表示。所列机构为 研究中心,而研究中心不一定是研究者所在的机构。 具体目标 比较目前接受相似剂量洛匹那韦/利托那韦(LPV/RTV)的HIV-1感染男性和女性的药代动力学(PK)参数、洛匹那韦(LPV)的浓度-时间曲线下面积(AUC)。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. SPECIFIC AIMS To compare the pharmacokinetic (PK) parameter, area under the concentration-time curve (AUC) of Lopinavir (LPV) between HIV-1-infected men and women currently receiving similar doses of Lopinavir/ritonavir (LPV/RTV).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
AIDS Clinical Trials Group for Research on Therapeutics for HIV and Related Infections
AIDS Clinical Trials Group for Research on Therapeutics for HIV and Related Infections
CoVPN 3008 A Phase 3, Multi-Center, Randomized, Efficacy Study of COVID-19 mRNA Vaccine in Regions with SARS-CoV-2 Variants of Concern
UCLA-CDU CFAR